Recap: aTyr Pharma Q4 Earnings

aTyr Pharma LIFE reported its Q4 earnings results on Thursday, March 14, 2024 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

aTyr Pharma missed estimated earnings by -4.0%, reporting an EPS of $-0.25 versus an estimate of $-0.24.

Revenue was down $10.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 3.0% drop in the share price the next day.

Here's a look at aTyr Pharma's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.23 -0.28 -0.40 -0.48
EPS Actual -0.20 -0.22 -0.29 -0.26
Revenue Estimate 1.50M 520K 300K 210K
Revenue Actual 353K 0 0 10.39M

To track all earnings releases for aTyr Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!